Biohaven Ltd. (BHVN)

NYSE: BHVN · USD

$15.4

+0.15 (+1.0%)· Recorded snapshot

Market cap	2.3B
Net income (ttm)	-586.8M
EPS (ttm)	-$4.48
Shares out	151M
Volume	2,534,658
Beta	3.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -586.8M
EPS (ttm): -$4.48
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-799.5

P25 n/aP50 n/aP75 n/a

ROIC-90.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BHVN indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001935979
Company name	Biohaven Ltd.
Country	United States
Country code	US
CUSIP number	G1110E107
Earnings date	2026-11-09
Earnings time	amc
Employees	274
Employees change	18
Employees growth	7.03%
Enterprise value	$2.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2017-05-04
Is primary listing	Yes
Is SPAC	No
ISIN number	VGG1110E1079
Last 10-K release date	2026-03-02
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$15.45
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	BHVN
U.S. state	Connecticut
Website	https://www.biohaven.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.98%
FCF / EV yield	-21.4%
FCF yield	-21.67%
Forward EV/Sales	20.72x
Forward P/S	20.47x
P/B ratio	188.93x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-2.1M
ROA	-71.98%
ROA (5Y)	-84.74%
ROCE	-172.17%
ROE	-799.46%
ROE (5Y)	-204.69%
ROIC	-90.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	7
EPS growth years	1
Net income growth quarters	3
Net income growth years	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-475,000
Depreciation and amortization	$10.3M
EBIT	$-530.4M
EBITDA	$-520.1M
EPS	$-4.48
FCF per share	$-3.39
Financing cash flow	$371.7M
Free cash flow	$-511.9M
Free cash flow minus SBC	$-597.8M
Income taxes	$1.2M
Investing cash flow	$211.3M
Net cash flow	$71.6M
Net income	$-586.8M
Operating cash flow minus SBC	$-597.3M
Operating income	$-530.4M
Stock-based compensation	$85.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.08
Debt / equity	24.3
Goodwill	$1.4M
Long-term assets	$74.2M
Long-term liabilities	$295.9M
Net cash (debt)	$-29.2M
Net cash / market cap	-1.23%
Net debt / equity	2.39
Piotroski F-Score	2
Property, plant and equipment	$51.9M
Shareholders' equity	$12.2M
Tangible book value	$-7.6M
Tangible book value per share	$-0.05
Total assets	$370.7M
Total cash	$267.9M
Total debt	$297M
Total liabilities	$358.5M
WACC	19.43%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$296.6M
Current liabilities	$62.7M
Current ratio	4.73
Net working capital	$-29.3M
Quick ratio	4.28
Working capital	$233.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-30.82%
Dividend yield	0%
Shareholder yield	-30.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.53
1D price change	1.01%
1M price change	19.17%
1M total return	19.17%
1W price change	31.08%
1W total return	31.08%
1Y price change	-10.98%
1Y return CAGR	-10.99%
1Y total return	-10.98%
20-day SMA	$12.60
200-day SMA	$12.18
3M price change	6.69%
3M total return	6.69%
3Y price change	-42.32%
3Y return CAGR	-16.76%
3Y total return	-42.32%
50-day SMA	$13.54
50-day SMA vs 200-day SMA	50over200
52-week high	$18.57
52-week high date	2025-10-30
52-week low	$7.48
52-week low date	2025-11-11
6M price change	61.42%
6M total return	61.42%
All-time high	$62.21
All-time high date	2024-03-08
All-time low	$5.54
All-time low date	2022-10-03
Average true range (ATR)	$1.08
Average volume	3.6M
Beta (1Y)	2.16
Beta (2Y)	1.6
Beta (5Y)	3.2
Change from 52-week high	-16.81%
Change from 52-week low	106.48%
Change from all-time high	-75.12%
Change from all-time low	179.42%
Change from open	1.08%
Day's gap	-0.07%
Dollar volume	$39.1M
High price	$15.86
Low price	$15.25
Monthly RSI	47.59
Open price	$15.28
Position in 52-week range	31.97%
Premarket change	-2.45%
Premarket close	$15.29
Premarket price	$14.92
Premarket volume	374
Previous close	$15.29
Price vs 150-day SMA	23.58%
Price vs 20-day SMA	22.85%
Price vs 200-day SMA	27.09%
Price vs 50-day SMA	14.35%
Relative volume	0.71
RSI	65.14
Sharpe ratio	0.32
Sharpe ratio (3Y)	0.12
Sortino ratio	0.53
Sortino ratio (3Y)	0.24
Volume	2.5M
Weekly RSI	57.94
YTD price change	37.11%
YTD total return	37.11%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	116.6M
Float percentage	77.18%
Shares change (QoQ)	2.05%
Shares change (YoY)	30.82%
Shares held by insiders	10.94%
Shares held by institutions	82.91%
Shares outstanding	151M
Short % of float	16.34%
Short % of shares	12.61%
Short ratio	6.3 days

Deeper analysis on BHVN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BHVN report

Is a complete BHVN research report available?

No complete published report is available for Biohaven Ltd. (BHVN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Biohaven Ltd. (BHVN)

Price

Financial snapshot

Fair-value bridge

Latest news · BHVN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BHVN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BHVN

Frequently asked questions